CancerBiolMed2023.doi:10.20892/j.issn.2095-3941.2022.0585CONSENSUS2022Chineseexpertconsensusandguidelinesonclinicalmanagementoftoxicityinanti-CD19chimericantigenreceptorT-celltherapyforB-cellnon-HodgkinlymphomaPingLi1*,YangLiu2*,YunLiang3*,JianBo4,SujunGao5,YongxianHu6,YuHu7,HeHuang6,XiaojunHuang8,HongmeiJing9,XiaoyanKe9,JianyongLi10,YuhuaLi11,QifaLiu12,PeihuaLu13,HengMei7,TingNiu14,YongpingSong15,YuqinSong16,LipingSu17,SanfangTu11,JianxiangWang18,DepeiWu19,ZhaoWang20,KailinXu21,ZhitaoYing16,QingmingYang2,YajingZhang2,FengxiaShi2,BinZhang22,HuilaiZhang23,XiZhang24,MingfengZhao25,WeiliZhao26,XiangyuZhao8,LiangHuang27,JunZhu16,WenbinQian3,WeidongHan2,AibinLiang11DepartmentofHematology,ShanghaiTongjiHospital,TongjiUniversitySchoolofMedicine,Shanghai200065,China;2DepartmentofBio-therapeutic,ChinesePLAGeneralHospital,Beijing100853,China;3DepartmentofHematology,TheSecondAffiliatedHospital,CollegeofMedicine,ZhejiangUniversity,Hangzhou310009,China;4DepartmentofHematology,ChinesePLAGeneralHospital,Beijing100853,China;5DepartmentofHematology,TheFirstHospitalofJilinUniversity,Changchun130012,China;6CenterforBoneMarrowTransplantation,TheFirstAffiliatedHospital,SchoolofMedicine,ZhejiangUniversity,Hangzhou310058,China;7InstituteofHematology,UnionHospitalofTongjiMedicalCollege;HuazhongUniversityofScienceandTechnology,Wuhan430022,China;8PekingUniversityPeople’sHospital&PekingUniversityInstituteofHematology,BeijingKeyLaboratoryofHematopoieticStemCellTransplantation,Beijing100044,China;9DepartmentofHematology,LymphomaResearchCenter,PekingUniversityThirdHospital,Beijing100191,China;10DepartmentofHematology,TheFirstAffiliatedHospitalofNanjingMedicalUniversity,JiangsuProvinceHospital,Nanjing210029,China;11DepartmentofHematology,ZhujiangHospital,SouthernMedicalUniversity,Guangzhou510280,China;12DepartmentofHematology,NanfangHospital,SouthernMedicalUniversity,Guangzhou510515,China;13LuDaopeiInstituteofHematology,Beijing101102,China;14DepartmentofHematology,WestChinaHospital,SichuanUni...
